Rob Hopfner is a Managing Partner at Pivotal bioVenture Partners where he invests in life sciences from company creation and seed through late stage and post-IPO. He invests in companies across North America and Europe. He serves on the boards of LAND Therapeutics, Evommune, and Plexium, and has invested in companies like Inozyme Pharma, Oculis, Vaxcyte, Evommune, and Plexium. Before Pivotal bioVenture Partners, he was Managing Director and Partner at Bay City Capital, and earlier a Principal at Bay City Capital. Rob studied at the University of Chicago Booth School of Business, Harvard Medical School, and the University of Saskatchewan, and lives in San Francisco.
Rob Hopfner, Managing Partner @ Pivotal bioVenture. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Rob Hopfner from Pivotal bioVenture Partners. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Rob
Map your path to Rob instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Rob
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.